In this study molecular modelling is introduced as a novel approach for the development of pharmaceutical solid dispersions. A computational model based on quantum mechanical (QM) calculations was used to predict the miscibility of various drugs in various polymers by predicting the binding strength between the drug and dimeric form of the polymer. The drug/polymer miscibility was also estimated by using traditional approaches such as Van Krevelen/Hoftyzer and Bagley solubility parameters or Flory Huggins interaction parameter in comparison to the molecular modelling approach.
INTRODUCTION
Drug-polymer miscibility is a significant factor to consider when designing solid dispersions for pharmaceutical dosage forms 1 . The interactions between small molecule drugs and polymers in a polymeric matrix system determines the nature of the drug loading inside the polymer matrix, such as oversaturated or under saturated, thus play a vital role in determining the long-term stability of the formulated product. Therefore, the characterisation and prediction of drug-polymer miscibility and more importantly drug solubility at various conditions has become an emerging topic in pharmaceutical research for the development of solid dispersions [1] [2] [3] . The dispersion of a small drug molecule being miscible into a polymer matrix is mechanistically a complex process. Both the repulsive and attractive intra-and intermolecular forces (e.g. dispersion force, dipole-dipole interaction, and hydrogen bonding forces) present in the system may further complicate the process. As a mechanistic rule, the molecular level mixing requires a step of balancing and/or breaking the crystalline lattice of drug molecules (with high activation energy) in the first instance. Subsequently, the polymer swelling (a process of polymer chain segment absorbing drug molecule) and rebuilding of the possible interactions inside the mixture occur 4 . The drug molecule (either crystalline or amorphous) may have significantly different physical properties within the polymer matrices after processing due to the different energy input and possible inter-molecular interactions that are required to form a solid dispersion. In terms of the random distribution of small drug molecules into the polymeric matrices, the miscible drug content demonstrates amorphous characteristics.
The lattice-based Flory-Huggins (F-H) theory (Flory 1952 ) is well known for the prediction of polymer-solvent or polymer-polymer interactions based on the Gibbs free energy change before and after mixing 5 . The F-H theory can be successfully applied to determine the interaction parameter therefore signifying the strength of the interactions between two compounds during their melting. Recent publications applying the F-H theory in solid dispersions focus on obtaining the F-H interaction parameter, χ, by the melting point depression method 6, 7 . The employment of F-H theory for the prediction of the intermolecular interactions in pharmaceutical binary systems can provide important insights in the development of solid dispersions processed by hot melt extrusion (HME) for example.
However, the theory assumes random distribution of the segments, which may not be suitable in cases where there are strong polar forces or specific interactions, such as hydrogen 4 bonding, between the components of the blends 8 . A deeper understanding of the relatively stronger interactions between the drug and the polymer has to be built on insights of the atomic level interactions. Molecular modelling approach is a powerful addition to the F-H theory to characterise the drug-polymer interactions through both visualisation of the interaction and estimation of the strength of the interactions. To date, a number of molecular mechanics (MM)-based molecular dynamics (MD) simulation studies [9] [10] [11] [12] have been performed to study various molecules (e.g. dissolution of the molecules from the crystal surface) 13 or to identify drug-polymer miscibility in solid dispersions [14] [15] [16] [17] [18] . Recently, we 19 reported the use of quantum mechanical (QM) calculations with commercially available software (Gaussian 09) to characterise possible drug/polymer interactions. Our calculations indicated the existence of hydrogen bonding between the amine group of the drug molecule and the carboxyl groups of the polymer among different drug/polymer formulations, which was subsequently, confirmed by NMR and X-ray photoelectron spectroscopy (XPS) studies.
In recent years, hot-melt extrusion (HME) has undergone a renaissance in the research and development of pharmaceutical formulations 20 . HME is a manufacture processing technology that combines the advantages of a solvent-free solid dispersion and has been used for a wide range of solid dispersion with increased drug solubility, taste masking of bitter APIs, and sustained/controlled release properties 20, 21 .
In this study, we developed a new approach to determine the drug-polymer miscibility based on quantum mechanical (QM) calculations, whereby the calculated binding energy between the drug and the polymer provides a strong indication for the formation of stable solid dispersions. The QM approach was compared with the Hansen solubility parameters and F-H estimated values in order to demonstrate the superiority of the molecular modelling approach, which not only provides more accurate description of the drug-polymer interaction energy, but also predicts the interacting functional groups between both substances. The latter was confirmed by X-ray photoelectron spectroscopy (XPS) 22, 23 studies on the produced HME solid dispersions. XPS has been reported as a valuable tool for the characterisation of solid dispersions by providing information on the nature (e.g. H-bonding) and specific site of chemical bonding on the surface of the solid dispersion.
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MATERIALS AND METHODS
Materials.
Propranolol HCl (PRP) and Diphenhydramine HCl (DPD), Paracetamol (PMOL), Ibuprofen (IBU), Dichlofenac Na (Df-Na) and Hydrocortisone (HCS) were purchased from Sigma Aldrich (London, UK) of ≥ 98% purity. Eudragit L100 (L100), Eudragit EPO (EPO)
and Eudragit L100-55 were kindly donated by Evonik Pharma Polymers (Darmstadt, Germany). Kollidon VA64 (VA64) was kindly donated by BASF (Germany). All materials were used as received.
Hot-melt extrusion (HME) processing. Drug/polymer blends (PRP/L100, PRP/L100-55, DPD/L100, DPD/L100-55, PMOL/VA64, IBU/VA64 and IBU/EPO) were blended in 100 g batches for 10 min each with a Turbula (TF2, Basel) mixer. The extrusion of all batches was performed using a Randcastle single-screw extruder (RCP0625) equipped with a 5-mm rod die at 100°C/140°C/155°C/155°C/150°C (Feeder → Die) temperature profiles for PRP and DPD based formulations, 100°C/113°C/115°C/115°C/115°C (Feeder → Die) for PMOL and 70°C/85°C/85°C/85°C/80°C (Feeder → Die) for IBU based formulations. The screw speed was set at 15rpm for all drug/polymer binary compositions. The produced extrudates (strands) were grinded by using a Ball Mill system (Retsch, Germany) to obtain granules (<500 µm) at a rotational speed of 400 rpm for 5 min. The drug-polymers composition consisted of PRP/L100, PRP/L100-55, DPD/L100 and DPD/L100-55 were extruded at ratios of 10/90 w/w. These four extruded formulations (comprising oppositely charged drugs and polymers) were used in XPS analysis to determine possible intermolecular interactions.
Hansen solubility parameters: Predictions of drug/polymers miscibility. The theoretical drug-polymers miscibility was determined by applying the Hansen solubility parameters (δ)
for both drugs as well as the polymers. The Hoftyzer and van Krevelen method was used to calculate all drug polymers solubility parameters by considering the chemical structural orientations 24 according to the following equation:
Here, Table 2 binary mixtures were calculated by using the following equations. The value determined by Eq. 3 represents the interactions between the two substances, specifically at the melting temperature, which may not be extrapolated to other temperatures.
Where, υ is the molar volume of the repeating unit, m is the degree of polymerization, φ is the volume fraction and χ is the crystalline-amorphous polymer interaction parameter, T m is the crystalline melting peak of the pure drugs and T o m is the melting endotherm of the drugpolymer physical blends. Where, R is the gas constant, T is the absolute temperature, and v the volume per lattice site and δ drug and δ poly are solubility parameters of drugs and polymers respectively.
Thermal analysis (DSC and MTDSC).
A Mettler-Toledo 823e (Greifensee, Switzerland) differential scanning calorimeter (DSC) was used to carry out thermal analysis of the bulk APIs, polymers, drug/polymer binary physical mixtures and extruded formulations (n=3). X-ray photoelectron spectroscopy (XPS) analysis. X-ray photoelectron spectra (XPS) were measured on a Kratos Axis Ultra-DLD using a monochromatic Al K α X-ray source (120 W)
and an analyser pass energy of 160 eV (survey scans) or 20 eV (high resolution scans); the pressure during analysis was 1×10 -9 Torr. All data were referenced to the C(1s) signal at 285.0 eV attributable to unsaturated C-C/C-H bonds 22 . Quantification and curve fitting was performed in CasaXPS TM (Version 2.3.15) using elemental sensitivity factors supplied by the manufacturer. All samples were run in triplicate.
RESULTS AND DISCUSSIONS
Predictions of drug/polymers miscibility: Hansen solubility parameters. Up to date there are several approaches employed to estimate the drug/polymer miscibility based in the determination of the solubility parameter. The theoretical approaches derived from the solubility parameter calculations suggest that compounds (e.g. drug or polymer) with similar .
It can be seen in Table 1 , respectively suggesting that both HCS and Df-Na are likely to be miscible with L100. On the other hand PMOL is unlikely to be miscible with EPO as the calculated ∆δ falls in the range close to 7MPa 1/2 threshold while IBU seems highly miscible with EPO (∆δ is 3.59 MPa 1/2 ). However, both PMOL and IBU are miscible with VA64.
Furthermore, to determine the solubility parameters more precisely a two-dimensional approach introduced by Bagley et al. 25 can be also used to predict drug-polymer miscibility (Table 1 ). Previous studies showed that, even though Van-Krevelen method has widely been used to screen drug/polymer miscibility, the estimated solubility parameters were not always accurate. For example, Maniruzzaman et al. 20 reported a study where the difference of the calculated partial solubility parameters of the model drug PMOL and the VA64 polymer was less than 7 MPa 1/2 . However, PMOL/VA64 were found immiscible and the solid-state characterisation (e.g. DSC, XRPD) showed that PMOL existed as separate amorphousamorphous phase from the polymer after extrusion. In the same study the Bagley approach provided a more accurate estimation of the drug-polymer miscibility complementing the findings from the solid-state analysis.
Therefore, the two -dimensional approach is used to determine the drug -polymer miscibility by calculating the distance (R a(v) ) using the Pythagorean Theorem 20 . By this approach two components are considered miscible when R a(v) ≤5.6MPa 1/2 . Table 1 shows that the δ h values of the polymers are substantially different compared to the δ p and δ d .
However the distances calculated for DPD/L100, DPD/L100-55, PRP/L100 and PRP/L100-55 blends indicate that both DPD and PRP are miscible with L100 and L100-55 polymers.
Similarly, R a(v) values calculated for Df-Na/L100 (6.97 MPa 1/2 ) and HCS/L100 (2.95 MPa The Hansen solubility parameter is considered a reliable approach to predict possible drug polymer miscibility, but the limited available data for different group contributions render this approach questionable. It does not also take in account the effect of chain conformation, including branching and linkages between monomer units and the molecular weight (MW) of compounds. These are considered important factors for the solubility of the drug molecule into polymer matrixes and thus in many cases the calculated solubility parameters provide misleading estimations of the drug/polymer miscibility.
Flory Huggins (F-H) theory for the prediction of drug/polymers interaction parameter.
The Flory-Huggins (F-H) theory is another approach that describes the polymer-drug or polymer-polymer miscibility on the basis of Gibbs free energy change before and after mixing. It assumes that each molecule occupies one site in the lattice and assumes random distribution of the segments 31 . The presence of strong bonds or intermolecular forces (e.g. Hbonding) in solid dispersions often limits the mobility of the chains, which are forced into non-random configurations 6, 31 . Therefore, the presence of such strong interactions in the systems makes the suitability of F-H theory unsatisfactory as it underestimates those interactions.
In order to determine the F-H interaction parameter between the investigated drugspolymers blends, the heat of fusion and melting peaks of bulk drug substances, polymers and physical blends were determined by thermal analysis. In the DSC thermograms the bulk PRP, DPD, HCS, Df-Na, PMOL and IBU showed sharp melting peaks at 166. Table 2 .
The negative values of the interaction parameter in Table 2 indicate that there is a net attraction force (such as dispersion, polar or hydrogen bonding) between the components in a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 10 binary mixture. Therefore higher absolute values of χ, suggest stronger interactions between drug/polymers blends. In Table 2 , it can be seen that L100 facilitates stronger interactions with different drugs compared to those of L100-55. Similarly, PMOL showed a stronger interaction with VA64 compared to that of EPO, which is in agreement with the solubility parameter calculations. As expected, IBU also showed relatively strong interactions with both EPO and VA64.
As mentioned in a previous paragraph, the F-H parameter cannot provide successful (Table 3 , Supp. Fig. 1-7 ).
Thermal analysis has been used as a valuable tool to predict drug-polymer miscibility 19, [32] [33] [34] .
According to the Gordon-Taylor equation, if a drug and polymer are miscible the mixture will show a single Tg that ranges between the Tg of pure components 20 . Thus, the theoretical prediction of Hansen solubility parameters by using Van Krevelen method and F-H interaction parameters was complemented by DSC studies to access drug /polymer miscibility.
The DSC results of bulk drug substances, bulk polymers, physical mixtures and melt extrudates are presented in Table. 3. All physical mixtures exhibited melting peaks of the drug at slightly decreasing melting temperatures due to possible drug/polymer interactions and partial miscibility. In contrast, no drug melting transitions were observed PRP/L100, PRP/L100-55, DPD/L100 and DPD/L100 solid dispersions prepared by HME processing.
The solid dispersions exhibited only a single Tg at temperatures between the Tg of the drug and the polymer, which is strong evidence that PRP and DPD are miscible with both L100
and L100-55 polymers. Similar results were also obtained for the other drug/polymer blends with an exception for the PMOL/VA64 extrudates where a phase separation was observed (PMOL and VA64 were present in two distinct amorphous phases). Molecular Modelling. Molecular modelling has been used extensively to assist in understanding experimental data and to predict the atomic and molecular properties that can provide guidance for experiment design. In the current study, the computation of binding strength between the drug and dimeric form of the polymer was carried out with a QM-based molecular modelling approach using commercial software package Gaussian09. In the QMbased calculations, the total energy of the system is calculated with respect to all atomic coordinates and thus the sum of electronic energy and repulsion energy between the nuclei and electrons. Because all electrons within the system are explicitly considered, the QM approach is capable of characterising with accuracy non-bonded interactions, such as hydrogen bonds and charge-charge interactions. Nonetheless, the present approach focuses on the intrinsic strength of H bonds and charge-charge interactions between the drug molecule and a small fragment of the polymer, which represents predominantly the polar forces present within the complex of drug-polymer carrier ( Fig. 1-2 ). It does not take consideration of the effect of the full polymeric matrix to drug loading and the process of polymer chain swelling to absorb the drug molecules, both of which can also play a part in determining drug-polymer miscibility. Thus, the binding energy obtained from our QM calculations should be an underestimate compared to the free energy estimated using the F-H theory.
A range of polymers (in their dimeric form) and model drugs were selected to study the strength of hydrogen bonding interactions and to probe the feasibility of identifying possible drug -polymer interactions prior the manufacturing of solid dispersions. The drugpolymer interaction patterns were identified by placing the drug molecule within the proximity of the dimer and then energy optimised to a local energy minimum. Based on these optimised configurations of drug-dimer interactions, the binding energy was calculated using the following equation:
The term E binding is the electronic energy component and also the dominant component of the enthalpy term (∆H) for the formation of the drug-dimer complexes. In all of the drug/polymers combinations primarily two different H bonding were detected with the donoracceptor distance at ~2 Å. All possible H bonding were shown in dash line in Table 4 .
Because the dimers and the drugs interact predominantly through hydrogen bonds, we interpret the calculated binding energy as a reflection of the strength of hydrogen bonds.
Overall, the strength of the interactions is dependent on both the type of the donor and acceptor and the number of hydrogen bonds formed between the drug and the polymer ( Figure 3 and Table 4 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 bond between the polymer and the drug may be accompanied by a ~5 to 8 kcal/mol increase in binding energy. . The BE peak at ~402.80 eV (higher than typically observed for amines BE= ~399 eV -400.5 eV and much more for -NH 2 + group) for N1s is an indication of C-O-NH 2 + structure whereas the O atom peak at ~534.40 eV shows the same 39, 40 . These results strongly indicate H-bonding interactions between the amine group of the API and ester/carboxyl group of the polymer (L100) (Fig. 6) .
X-ray Photoelectron Spectroscopy (XPS) analysis. XPS analysis was employed to
Similarly, N 1s peaks from PRP/L100-55 and DPD/L100-55 also complement the observations from PRP/L100 and DPD/L100 formulations. The N (1s) energy of ~402.9 eV in DPD/L100 formulation suggests protonation of the amine group as observed for aforementioned PRP/L100 formulation. The BE peak at ~402.90 eV (Fig. 7) for N1s is an indication of C-O-NH 2 + structure with longer peak shift than that of PRP/L100. As before, we concluded that a strong interaction between the amine group of API and ester/carboxyl group of polymer through H-interactions has taken place [40] [41] [42] .
Furthermore, the calculation of the N-coefficient for all extruded formulations indicated the strength of the intermolecular interactions within the solid dispersions. The calculated N coefficients for all extruded formulations are summarized in Table 5 . The values 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   14 in Table 5 clearly show that the N coefficient values of the active L100 extrudates are smaller than those of L100-55 extrudates. It is accepted that the lower the N-coefficient, the higher the amount of protonated N atoms in cationic drugs and thus the stronger the interaction between polymer and APIs.
CONCLUSIONS
In this study, we exploited the use of quantum mechanical (QM) calculations to predict drugpolymer interactions by using the drug molecule and the dimeric form of the polymer. In 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Figures caption list Fig. 1 Molecular modelling of PRP and L100 or L100-55 pairs (Gaussian09).
Fig. 2
Molecular modelling of DPD with different polymers (energy optimised to local minima at the M06-2x/6-31G** level and verified by frequency calculations using Gaussian09).
Fig. 3
Binding energy as arranged based on the number of hydrogen bonds (red and blue columns for one H bond while green for two H bonds) between the dimeric structure of the polymer and the model drugs. Red columns represent the binding energy involved in tertiary amines. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Molecular modelling of DPD with different polymers (energy optimised to local minima at the B3LYP/6-31G* level and verified by frequency calculations using Gaussian09). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Binding energy as arranged based on the number of hydrogen bonds (red and blue columns for one H bond while green for two H bonds) between the dimeric structure of the polymer and the model drugs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Molecular structure of PRP and N 1s BE peaks of PRP and extruded formulations (from the peak fitting using CasaXPSTM -Version 2. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 DPD molecular structure and its N 1s BE peaks with DPD/L100 and DPD/L100-55 extruded formulations (peak fitting performed using CasaXPSTM -Version 2. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
